IDYAIDEAYA Biosciences, Inc.
- Market cap
- $3.35B
- as of 2026-10-23
- Latest close
- $34.71
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-11-07
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Hata Yujiro SPresident and CEO | Oct 6 | Oct 8 | M | 26,338 | $4.31 | $113,517 | 717,033 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Oct 6 | Oct 8 | S | 25,538 | $37.39 | Sale −$954,787 | 691,495 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Oct 6 | Oct 8 | S | 800 | $38.26 | Sale −$30,610 | 690,695 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Oct 6 | Oct 8 | M · derivative | 26,338 | $4.31 | $113,517 | 23,116 | Yes | Form 4 |
| Ruiz Briseno AndresChief Accounting Officer | Jul 7 | Jul 9 | M | 9,550 | $12.86 | $122,813 | 36,016 | Yes | Form 4 |
| Ruiz Briseno AndresChief Accounting Officer | Jul 7 | Jul 9 | S | 9,550 | $40.01 | Sale −$382,096 | 26,466 | Yes | Form 4 |
| Ruiz Briseno AndresChief Accounting Officer | Jul 7 | Jul 9 | M · derivative | 9,550 | $12.86 | $122,813 | 19,200 | Yes | Form 4 |
| Hampton Malcolm Garret | Jun 16 | Jun 18 | A · derivative | 20,000 | $30.57 | $611,400 | 20,000 | No | Form 4 |
| Mackey Catherine J | Jun 16 | Jun 18 | A · derivative | 20,000 | $30.57 | $611,400 | 20,000 | No | Form 4 |
| Morrison Scott W | Jun 16 | Jun 18 | A · derivative | 20,000 | $30.57 | $611,400 | 20,000 | No | Form 4 |
| Rosen Terry J | Jun 16 | Jun 18 | A · derivative | 20,000 | $30.57 | $611,400 | 20,000 | No | Form 4 |
| Stein Jeffrey | Jun 16 | Jun 18 | A · derivative | 20,000 | $30.57 | $611,400 | 20,000 | No | Form 4 |
| Yarno Wendy L | Jun 16 | Jun 18 | A · derivative | 20,000 | $30.57 | $611,400 | 20,000 | No | Form 4 |
| Stein Jeffrey | Mar 2 | Mar 2 | P | 50,000 | $32.96 | Purchase +$1,648,000 | 54,281 | No | Form 4 |
| Ruiz Briseno AndresSee Remarks | Jan 30 | Feb 2 | A · derivative | 80,000 | $32.19 | $2,575,200 | 80,000 | No | Form 4 |
| Snyder Douglas B.SVP, General Counsel | Jan 30 | Feb 2 | A · derivative | 130,000 | $32.19 | $4,184,700 | 130,000 | No | Form 4 |
| Hata Yujiro SPresident and CEO | Jan 30 | Feb 2 | A · derivative | 600,000 | $32.19 | $19,314,000 | 600,000 | No | Form 4 |
| Dorman StuartChief Commercial Officer | Jan 30 | Feb 2 | A · derivative | 155,000 | $32.19 | $4,989,450 | 155,000 | No | Form 4 |
| Beaupre DarrinChief Medical Officer | Jan 30 | Feb 2 | A · derivative | 175,000 | $32.19 | $5,633,250 | 175,000 | No | Form 4 |
| White Michael AnthonyChief Scientific Officer | Jan 30 | Feb 2 | A · derivative | 190,000 | $32.19 | $6,116,100 | 190,000 | No | Form 4 |
| Bleharski JoshuaChief Financial Officer | Jan 30 | Feb 2 | A · derivative | 170,000 | $32.19 | $5,472,300 | 170,000 | No | Form 4 |
| Ruiz Briseno AndresSee Remarks | Nov 28, 2025 | Feb 2 | A | 1,253 | $16.91 | $21,188 | 26,466 | No | Form 4 |
| Snyder Douglas B.SVP, General Counsel | Nov 28, 2025 | Feb 2 | A | 1,041 | $16.91 | $17,603 | 2,080 | No | Form 4 |
| Snyder Douglas B.SVP, General Counsel | May 30, 2025 | Feb 2 | A | 1,039 | $16.91 | $17,569 | 1,039 | No | Form 4 |
| Ruiz Briseno AndresSee Remarks | Nov 29, 2024 | Feb 2 | A | 682 | $23.26 | $15,863 | 25,213 | No | Form 4 |
| Rosen Terry J | Jun 24, 2025 | Jun 26, 2025 | A · derivative | 20,000 | $21.78 | $435,600 | 20,000 | No | Form 4 |
| Mackey Catherine J | Jun 24, 2025 | Jun 26, 2025 | A · derivative | 20,000 | $21.78 | $435,600 | 20,000 | No | Form 4 |
| Morrison Scott W | Jun 24, 2025 | Jun 26, 2025 | A · derivative | 20,000 | $21.78 | $435,600 | 20,000 | No | Form 4 |
| Hampton Malcolm Garret | Jun 24, 2025 | Jun 26, 2025 | A · derivative | 20,000 | $21.78 | $435,600 | 20,000 | No | Form 4 |
| Stein Jeffrey | Jun 24, 2025 | Jun 26, 2025 | A · derivative | 20,000 | $21.78 | $435,600 | 20,000 | No | Form 4 |
| Yarno Wendy L | Jun 24, 2025 | Jun 26, 2025 | A · derivative | 20,000 | $21.78 | $435,600 | 20,000 | No | Form 4 |
| Hata Yujiro SPresident and CEO | Feb 27, 2025 | Feb 28, 2025 | A · derivative | 600,000 | $20.24 | $12,144,000 | 600,000 | No | Form 4 |
| Snyder Douglas B.SVP, General Counsel | Feb 27, 2025 | Feb 28, 2025 | A · derivative | 33,000 | $20.24 | $667,920 | 33,000 | No | Form 4 |
| White Michael AnthonyChief Scientific Officer | Feb 27, 2025 | Feb 28, 2025 | A · derivative | 185,000 | $20.24 | $3,744,400 | 185,000 | No | Form 4 |
| Ruiz Briseno AndresSee Remarks | Feb 27, 2025 | Feb 28, 2025 | A · derivative | 75,000 | $20.24 | $1,518,000 | 75,000 | No | Form 4 |
| Dorman StuartChief Commercial Officer | Feb 27, 2025 | Feb 28, 2025 | A · derivative | 15,000 | $20.24 | $303,600 | 15,000 | No | Form 4 |
| Beaupre DarrinChief Medical Officer | Feb 27, 2025 | Feb 28, 2025 | A · derivative | 185,000 | $20.24 | $3,744,400 | 185,000 | No | Form 4 |
| Hata Yujiro SPresident and CEO | Feb 18, 2025 | Feb 19, 2025 | M | 12,808 | $19.52 | $250,012 | 690,695 | No | Form 4 |
| Hata Yujiro SPresident and CEO | Feb 18, 2025 | Feb 19, 2025 | M · derivative | 12,808 | $19.52 | $250,012 | 182,192 | No | Form 4 |
| Snyder Douglas B.SVP, General Counsel | Sep 26, 2024 | Sep 27, 2024 | A · derivative | 140,000 | $30.50 | $4,270,000 | 140,000 | No | Form 4 |
| Throne JasonChief Legal Officer | Jun 27, 2024 | Jun 27, 2024 | M | 6,424 | $13.34 | $85,696 | 16,424 | No | Form 4 |
| Throne JasonChief Legal Officer | Jun 27, 2024 | Jun 27, 2024 | M | 47,060 | $7.01 | $329,891 | 63,484 | No | Form 4 |
| Throne JasonChief Legal Officer | Jun 27, 2024 | Jun 27, 2024 | M · derivative | 6,424 | $13.34 | $85,696 | 41,186 | No | Form 4 |
| Throne JasonChief Legal Officer | Jun 27, 2024 | Jun 27, 2024 | M · derivative | 47,060 | $7.01 | $329,891 | 1,360 | No | Form 4 |
| Mackey Catherine J | May 31, 2024 | May 31, 2024 | A · derivative | 16,200 | $36.55 | $592,110 | 16,200 | No | Form 4 |
| Yarno Wendy L | May 31, 2024 | May 31, 2024 | A · derivative | 16,200 | $36.55 | $592,110 | 16,200 | No | Form 4 |
| Morrison Scott W | May 31, 2024 | May 31, 2024 | A · derivative | 16,200 | $36.55 | $592,110 | 16,200 | No | Form 4 |
| Stein Jeffrey | May 31, 2024 | May 31, 2024 | A · derivative | 16,200 | $36.55 | $592,110 | 16,200 | No | Form 4 |
| Hampton Malcolm Garret | May 31, 2024 | May 31, 2024 | A · derivative | 16,200 | $36.55 | $592,110 | 16,200 | No | Form 4 |
| Kelley Susan L. | May 31, 2024 | May 31, 2024 | A · derivative | 16,200 | $36.55 | $592,110 | 16,200 | No | Form 4 |
| Rosen Terry J | May 31, 2024 | May 31, 2024 | A · derivative | 16,200 | $36.55 | $592,110 | 16,200 | No | Form 4 |
| White Michael AnthonyChief Scientific Officer | May 29, 2024 | May 31, 2024 | M | 28,500 | $12.86 | $366,510 | 28,500 | Yes | Form 4 |
| White Michael AnthonyChief Scientific Officer | May 29, 2024 | May 31, 2024 | S | 27,649 | $36.23 | Sale −$1,001,723 | 851 | Yes | Form 4 |
| White Michael AnthonyChief Scientific Officer | May 29, 2024 | May 31, 2024 | S | 851 | $36.78 | Sale −$31,300 | not reported | Yes | Form 4 |
| White Michael AnthonyChief Scientific Officer | May 29, 2024 | May 31, 2024 | M · derivative | 28,500 | $12.86 | $366,510 | 64,000 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | May 16, 2024 | May 16, 2024 | M | 34,433 | $4.31 | $148,406 | 712,320 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | May 16, 2024 | May 16, 2024 | S | 30,084 | $41.73 | Sale −$1,255,405 | 682,236 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | May 16, 2024 | May 16, 2024 | S | 4,349 | $42.37 | Sale −$184,267 | 677,887 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | May 16, 2024 | May 16, 2024 | M · derivative | 34,433 | $4.31 | $148,406 | 49,454 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | May 15, 2024 | May 16, 2024 | M | 83,856 | $4.31 | $361,419 | 761,743 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | May 15, 2024 | May 16, 2024 | S | 53,592 | $42.57 | Sale −$2,281,411 | 708,151 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | May 15, 2024 | May 16, 2024 | S | 29,761 | $43.48 | Sale −$1,294,008 | 678,390 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | May 15, 2024 | May 16, 2024 | S | 503 | $44.12 | Sale −$22,192 | 677,887 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | May 15, 2024 | May 16, 2024 | M · derivative | 83,856 | $4.31 | $361,419 | 83,887 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | May 14, 2024 | May 16, 2024 | M | 56,711 | $4.31 | $244,424 | 734,598 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | May 14, 2024 | May 16, 2024 | S | 54,408 | $41.60 | Sale −$2,263,373 | 680,190 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | May 14, 2024 | May 16, 2024 | S | 2,303 | $41.84 | Sale −$96,358 | 677,887 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | May 14, 2024 | May 16, 2024 | M · derivative | 56,711 | $4.31 | $244,424 | 167,743 | Yes | Form 4 |
| Throne JasonChief Legal Officer | Mar 1, 2024 | Mar 4, 2024 | A · derivative | 125,500 | $46.22 | $5,800,610 | 125,500 | No | Form 4 |
| White Michael AnthonyChief Scientific Officer | Mar 1, 2024 | Mar 4, 2024 | A · derivative | 140,000 | $46.22 | $6,470,800 | 140,000 | No | Form 4 |
| Beaupre DarrinChief Medical Officer | Mar 1, 2024 | Mar 4, 2024 | A · derivative | 160,000 | $46.22 | $7,395,200 | 160,000 | No | Form 4 |
| Ruiz Briseno AndresSee Remarks | Mar 1, 2024 | Mar 4, 2024 | A · derivative | 85,000 | $46.22 | $3,928,700 | 85,000 | No | Form 4 |
| Hata Yujiro SPresident and CEO | Mar 1, 2024 | Mar 4, 2024 | A · derivative | 480,000 | $46.22 | $22,185,600 | 480,000 | No | Form 4 |
| Ruiz Briseno AndresSee Remarks | Feb 9, 2024 | Feb 13, 2024 | S | 2,000 | $46.02 | Sale −$92,040 | 24,531 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Feb 9, 2024 | Feb 12, 2024 | M | 23,557 | $4.31 | $101,531 | 701,444 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Feb 9, 2024 | Feb 12, 2024 | S | 23,557 | $45.54 | Sale −$1,072,786 | 677,887 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Feb 9, 2024 | Feb 12, 2024 | M · derivative | 23,557 | $4.31 | $101,531 | 224,454 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Feb 8, 2024 | Feb 12, 2024 | M | 75,815 | $4.31 | $326,763 | 753,702 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Feb 8, 2024 | Feb 12, 2024 | S | 75,815 | $45.15 | Sale −$3,423,047 | 677,887 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Feb 8, 2024 | Feb 12, 2024 | M · derivative | 75,815 | $4.31 | $326,763 | 248,011 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Feb 1, 2024 | Feb 5, 2024 | M | 628 | $4.31 | $2,707 | 678,515 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Feb 1, 2024 | Feb 5, 2024 | S | 624 | $45.00 | Sale −$28,080 | 677,891 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Feb 1, 2024 | Feb 5, 2024 | S | 4 | $45.01 | Sale −$180 | 677,887 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Feb 1, 2024 | Feb 5, 2024 | M · derivative | 628 | $4.31 | $2,707 | 323,826 | Yes | Form 4 |
| Ruiz Briseno AndresSee Remarks | Jan 22, 2024 | Jan 24, 2024 | S | 2,000 | $42.03 | Sale −$84,060 | 26,531 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Jan 16, 2024 | Jan 17, 2024 | M | 62,739 | $4.31 | $270,405 | 740,626 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Jan 16, 2024 | Jan 17, 2024 | S | 62,739 | $40.17 | Sale −$2,520,226 | 677,887 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Jan 16, 2024 | Jan 17, 2024 | M · derivative | 62,739 | $4.31 | $270,405 | 324,454 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Jan 12, 2024 | Jan 17, 2024 | M | 12,261 | $4.31 | $52,845 | 690,148 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Jan 12, 2024 | Jan 17, 2024 | S | 12,261 | $40.04 | Sale −$490,930 | 677,887 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Jan 12, 2024 | Jan 17, 2024 | M · derivative | 12,261 | $4.31 | $52,845 | 387,193 | Yes | Form 4 |
| Ruiz Briseno AndresSee Remarks | Jan 12, 2024 | Jan 17, 2024 | S | 2,000 | $38.01 | Sale −$76,020 | 28,531 | Yes | Form 4 |
| Throne JasonChief Legal Officer | Dec 18, 2023 | Dec 19, 2023 | M | 10,000 | $7.01 | $70,100 | 10,000 | Yes | Form 4 |
| Throne JasonChief Legal Officer | Dec 18, 2023 | Dec 19, 2023 | M · derivative | 10,000 | $7.01 | $70,100 | 48,420 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Dec 15, 2023 | Dec 19, 2023 | M | 75,000 | $4.31 | $323,250 | 752,887 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Dec 15, 2023 | Dec 19, 2023 | S | 75,000 | $35.03 | Sale −$2,627,250 | 677,887 | Yes | Form 4 |
| Hata Yujiro SPresident and CEO | Dec 15, 2023 | Dec 19, 2023 | M · derivative | 75,000 | $4.31 | $323,250 | 399,454 | Yes | Form 4 |
| Throne JasonChief Legal Officer | Dec 15, 2023 | Dec 19, 2023 | M | 10,000 | $13.34 | $133,400 | 10,000 | Yes | Form 4 |
| Throne JasonChief Legal Officer | Dec 15, 2023 | Dec 19, 2023 | S | 10,000 | $35.04 | Sale −$350,400 | not reported | Yes | Form 4 |
| Throne JasonChief Legal Officer | Dec 15, 2023 | Dec 19, 2023 | M · derivative | 10,000 | $13.34 | $133,400 | 47,610 | Yes | Form 4 |
| Ruiz Briseno AndresSee Remarks | Dec 14, 2023 | Dec 18, 2023 | S | 1,672 | $34.00 | Sale −$56,848 | 30,859 | Yes | Form 4 |
| Ruiz Briseno AndresSee Remarks | Dec 14, 2023 | Dec 18, 2023 | S | 328 | $34.01 | Sale −$11,155 | 30,531 | Yes | Form 4 |
| Throne JasonChief Legal Officer | Nov 3, 2023 | Nov 7, 2023 | M | 5,163 | $12.86 | $66,396 | 5,163 | Yes | Form 4 |
| Throne JasonChief Legal Officer | Nov 3, 2023 | Nov 7, 2023 | S | 5,163 | $30.09 | Sale −$155,355 | not reported | Yes | Form 4 |
| Throne JasonChief Legal Officer | Nov 3, 2023 | Nov 7, 2023 | M · derivative | 5,163 | $12.86 | $66,396 | 48,750 | Yes | Form 4 |